Ruthenium metallodendrimer against triple-negative breast cancer in mice
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved..
Carbosilane metallodendrimers, based on the arene Ru(II) complex (CRD13) and integrated to imino-pyridine surface groups have been investigated as an anticancer agent in a mouse model with triple-negative breast cancer. The dendrimer entered into the cells efficiently, and exhibited selective toxicity for 4T1 cells. In vivo investigations proved that a local injection of CRD13 caused a reduction of tumour mass and was non-toxic. ICP analyses indicated that Ru(II) accumulated in all tested tissues with a greater content detected in the tumour.
Media Type: |
Electronic Article |
---|
Year of Publication: |
2023 |
---|---|
Publication: |
2023 |
Contained In: |
To Main Record - volume:53 |
---|---|
Contained In: |
Nanomedicine : nanotechnology, biology, and medicine - 53(2023) vom: 15. Aug., Seite 102703 |
Language: |
English |
---|
Contributors: |
Michlewska, Sylwia [Author] |
---|
Links: |
---|
Keywords: |
Anticancer agent |
---|
Notes: |
Date Revised 27.08.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.nano.2023.102703 |
---|
funding: |
|
---|---|
Supporting institution / Project title: |
|
PPN (Catalogue-ID): |
NLM360979262 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM360979262 | ||
003 | DE-627 | ||
005 | 20230828232216.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230818s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nano.2023.102703 |2 doi | |
028 | 5 | 2 | |a pubmed23n1456.xml |
035 | |a (DE-627)NLM360979262 | ||
035 | |a (NLM)37591367 | ||
035 | |a (PII)S1549-9634(23)00054-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Michlewska, Sylwia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ruthenium metallodendrimer against triple-negative breast cancer in mice |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.08.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a Carbosilane metallodendrimers, based on the arene Ru(II) complex (CRD13) and integrated to imino-pyridine surface groups have been investigated as an anticancer agent in a mouse model with triple-negative breast cancer. The dendrimer entered into the cells efficiently, and exhibited selective toxicity for 4T1 cells. In vivo investigations proved that a local injection of CRD13 caused a reduction of tumour mass and was non-toxic. ICP analyses indicated that Ru(II) accumulated in all tested tissues with a greater content detected in the tumour | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Anticancer agent | |
650 | 4 | |a In vivo | |
650 | 4 | |a Ruthenium metallodendrimer | |
650 | 4 | |a Toxicity | |
650 | 4 | |a Tumour weight | |
700 | 1 | |a Wójkowska, Dagmara |e verfasserin |4 aut | |
700 | 1 | |a Watala, Cezary |e verfasserin |4 aut | |
700 | 1 | |a Skiba, Elżbieta |e verfasserin |4 aut | |
700 | 1 | |a Ortega, Paula |e verfasserin |4 aut | |
700 | 1 | |a de la Mata, Francisco Javier |e verfasserin |4 aut | |
700 | 1 | |a Bryszewska, Maria |e verfasserin |4 aut | |
700 | 1 | |a Ionov, Maksim |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomedicine : nanotechnology, biology, and medicine |d 2005 |g 53(2023) vom: 15. Aug., Seite 102703 |w (DE-627)NLM000057614 |x 1549-9642 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2023 |g day:15 |g month:08 |g pages:102703 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nano.2023.102703 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
936 | u | w | |d 53 |j 2023 |b 15 |c 08 |h 102703 |
951 | |a AR | ||
952 | |d 53 |j 2023 |b 15 |c 08 |h 102703 |